We are live on ! Find out more

Large Cap Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
RPRX icon
51
Royalty Pharma
RPRX
$25.7B
$25.7B $57.63 1.25%
ROIV icon
52
Roivant Sciences
ROIV
$25.6B
$25.6B $35.50 2.93%
DGX icon
53
Quest Diagnostics
DGX
$25.5B
$25.5B $231.09 0.85%
LH icon
54
Labcorp
LH
$24.7B
$24.7B $304.60 1.14%
UTHR icon
55
United Therapeutics
UTHR
$24.5B
$24.5B $571.38 5.44%
BNTX icon
56
BioNTech
BNTX
$24.3B
$24.3B $96.85 1.48%
INCY icon
57
Incyte
INCY
$23.7B
$23.7B $117.14 3.47%
INSM icon
58
Insmed
INSM
$23.7B
$23.7B $108.59 4.86%
GH icon
59
Guardant Health
GH
$23.5B
$23.5B $174.75 2.02%
PHG icon
60
Philips
PHG
$23.3B
$23.3B $23.81 2.54%
GMAB icon
61
Genmab
GMAB
$21.6B
$21.6B $34.55 3.17%
THC icon
62
Tenet Healthcare
THC
$20.4B
$20.4B $253.97 0.62%
STE icon
63
Steris
STE
$20.4B
$20.4B $209.34 0.32%
VTRS icon
64
Viatris
VTRS
$20.1B
$20.1B $17.46 1.47%
VHT icon
65
Vanguard Health Care ETF
VHT
$18.8B
$18.8B $311.72 1.38%
ZBH icon
66
Zimmer Biomet
ZBH
$16.8B
$16.8B $88.06 0.87%
MEDP icon
67
Medpace
MEDP
$16.7B
$16.7B $598.08 4.18%
RVTY icon
68
Revvity
RVTY
$16.6B
$16.6B $149.06 2.51%
JAZZ icon
69
Jazz Pharmaceuticals
JAZZ
$15.1B
$15.1B $233.01 0.64%
ASND icon
70
Ascendis Pharma A/S
ASND
$15B
$15B $227.31 0.23%
SOLV icon
71
Solventum
SOLV
$14.9B
$14.9B $87.77 0.43%
EXEL icon
72
Exelixis
EXEL
$14.4B
$14.4B $57.94 0.8%
NBIX icon
73
Neurocrine Biosciences
NBIX
$14.3B
$14.3B $140.71 0.8%
TEM
74
Tempus AI
TEM
$13.9B
$13.9B $76.50 6.59%
CRL icon
75
Charles River Laboratories
CRL
$13.7B
$13.7B $286.83 2.77%
1 2
3
4 5

Large Cap Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 101 large cap Healthcare stocks — companies in the Healthcare sector with a market cap between $10B and $200B — worth a combined $4.33T.

The largest by market cap are Gilead Sciences (GILD) at $183B, Abbott (ABT) at $167B and Novo Nordisk (NVO) at $165B.

Among institutional investors, CVS Health (CVS) drew the most net new fund positions in Q2 2026: 323 funds opened new positions, taking total fund holders up 194 (10%) quarter-over-quarter.

  • Combined market cap: $4.33T across 101 stocks.
  • Large Cap: market cap between $10B and $200B.
  • Largest constituent: Gilead Sciences (GILD), $183B market cap.
  • Most net new fund positions in Q2 2026: CVS Health (CVS), +194 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.